Cannabis Law Report

JULY 29, 2021

Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-looking statements. Some statements in this release may contain forward-looking information.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JUNE 14, 2022

There are multiple clinical centers doing research with psychedelics in Europe and, inevitably, regulatory approvals in Europe will follow. PAREA is coming together to address those challenges and provide evidence-based policy recommendations and expertise to the EU policymakers.

Access 52

Access Therapy Clinical Trials Treatment 52

The Cannigma

MAY 19, 2021

Japan has some of the harshest drug policies on Earth, including for cannabis — and is one of the worst places on Earth to get arrested on marijuana possession charges. The Tokyo Marijuana March has been held since 2001, though it’s a much more reserved and smoke-free event than its counterparts in many other countries.

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

JULY 29, 2021

of their dry weight and it is not practical to obtain meaningful pure amounts of these compounds from the flesh of mushrooms, at a reasonable cost, to conduct clinical trials in humans and to commercialize these products. The levels of these compounds in dried mushrooms are only 0.2% – 1.0% SOURCE Nova Mentis Life Science Corp.

Clinical Trials 105

Clinical Trials Conditions Packaging Events 105

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. Forward-looking statements are statements that relate to future, not past, events. Information set forth in this news release includes forward-looking statements under applicable securities laws.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

NOVEMBER 15, 2021

References: Statement from then FDA Commissioner Scott Gottlieb, MD, and Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies. News release. FDA website. January 15, 2019. 2021 Aug 26;23:119-127. doi: 10.1016/j.omtm.2021.08.006.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera is an accomplished cross-functional leader in the healthcare industry, with over 20 years of experience in the development and implementation of complex market access strategies including health policy, pricing and reimbursement, contracts and coding.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. She was Founder and Executive Producer of the award-winning future-shaping events series, Creative Innovation Global. He has a B.Sc.

Medicine 52

Medicine Therapy Research and Development Business 52

Canna Law Blog

OCTOBER 5, 2022

We could see medical marijuana in Japan in the near future, which would be huge for Asian cannabis policy and the world. ” However, that didn’t go anywhere aside from Japan quietly clearing Epidiolex for clinical trials for Dravet and Lennox-Gastaut syndromes back in 2019.

Marijuana 93

Marijuana Seed-To-Sale Clinical Trials Epilepsy 93

Project CBD

FEBRUARY 28, 2023

13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e., 17 Excerpted from HerbalGram , the quarterly publication of the American Botanical Council. Accessed July 25, 2021.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 12, 2021

In the event that the Maximum LTV is exceeded, Brown Shipley can make a call on the Guarantors requiring them to place cash with Brown Shipley for the aggregate amount of the excess exposure over the Maximum LTV. OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

MAY 7, 2021

Now, that’s going to matter significantly when as we advance clinical trials, as we advance product formulation as not just product formulation within pharma but all product formulation and that comes down to the initial process in relation to the supply chain of pretty hardcore standardization. MSO: Let’s pivot for a minute.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

JULY 15, 2022

Media event date: 27 August 2019. We are at the crossroads of good agriculture meets good health care which meets great policy. And when you have agriculture and health come together with strong robust government policy, we have new businesses emerge using the best intellectual property that the world has to offer.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

NOVEMBER 24, 2021

These publications offer valuable indicators for current debates and disputes, political contestations, demands for reform or policy change, reactions to research activities and evidence, as well as attitudes from the medical profession towards new treatments and therapies like medicinal cannabis. 23), followed by adverse events ( n ?=?15)

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Amanda Feilding, Countess of Wemyss and March is an English drug policy reformer, lobbyist and research coordinator. Andrew Yang.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

For non-US citizens, Malyshev explains, this can result in a lifetime ban from entry into the US under current policy. The FDA has started to hold hearings to determine whether it will change its policy on foods and beverages containing CBD made from industrial hemp, and CBD products more broadly.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

DECEMBER 30, 2019

After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019. Erik Altieri.

Legislation 59

Legislation Patients Access Banking 59